I think you're overestimating the urgency on the p
Post# of 72440
BP is risk adverse. They'd rather pay up big in a bidding war for something they're sure of rather than be early to the party but risk failure. Heads roll because of failure, not for missing out on success. This pipeline may be "once in a lifetime" for us IPIX investors but there's always another drug to buy and develop for BP.
You mistake our position at the table. The guy (all dozen of them) holding the $10B+ is in charge. I suspect we'll get our fair price because Leo is a shrewd and skillful business man but it will be on BP's time line. The ones that don't buy IPIX will buy the next next Regeneron, Receptos, Juno, etc.
Go IPIX!